Cargando…

Rapid increase in the incidence of end-stage renal disease in patients with type 1 diabetes having HbA1c 10% or higher for 15 years

The incidence of end-stage renal disease (ESRD) in Japanese patients with type 1 diabetes mellitus (T1DM) was investigated regarding the association between mean HbA1c values during follow-up and the duration of follow-up/illness. The study includes 988 patients diagnosed at ages younger than 30 yr....

Descripción completa

Detalles Bibliográficos
Autores principales: Otani, Toshika, Yokoyama, Hiroki, Hanai, Ko, Miura, Junnosuke, Uchigata, Yasuko, Babazono, Tetsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society for Pediatric Endocrinology 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801355/
https://www.ncbi.nlm.nih.gov/pubmed/31666764
http://dx.doi.org/10.1297/cpe.28.113
_version_ 1783460552965619712
author Otani, Toshika
Yokoyama, Hiroki
Hanai, Ko
Miura, Junnosuke
Uchigata, Yasuko
Babazono, Tetsuya
author_facet Otani, Toshika
Yokoyama, Hiroki
Hanai, Ko
Miura, Junnosuke
Uchigata, Yasuko
Babazono, Tetsuya
author_sort Otani, Toshika
collection PubMed
description The incidence of end-stage renal disease (ESRD) in Japanese patients with type 1 diabetes mellitus (T1DM) was investigated regarding the association between mean HbA1c values during follow-up and the duration of follow-up/illness. The study includes 988 patients diagnosed at ages younger than 30 yr. These patients were initially examined between 1962 and 1999, and HbA1 and/or HbA1c measurements were taken for at least 3 yr after 1980. The follow-up period was from the date of the first HbA1 or HbA1c measurement to the final measurement day, or HbA1c measurement day immediately before the development of ESRD. The condition progressed to ESRD in 63 patients (mean duration of illness: 23.6 yr). Cox regression analysis revealed that patients with HbA1c of ≥ 10% had a significantly increased higher risk than those with HbA1c under 8% (P < 0.0001). The HbA1c cut-off point was 10.0%. The HbA1c value was ≥ 10% at baseline and during follow-up in 128 patients. Assuming that HbA1c of ≥ 10% persisted since the time of diagnosis in these patients, the cumulative incidence of ESRD abruptly increased after 15 yr of illness. Thus, the incidence of ESRD increased after the persistence of HbA1c of ≥ 10% for 15 yr.
format Online
Article
Text
id pubmed-6801355
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher The Japanese Society for Pediatric Endocrinology
record_format MEDLINE/PubMed
spelling pubmed-68013552019-10-30 Rapid increase in the incidence of end-stage renal disease in patients with type 1 diabetes having HbA1c 10% or higher for 15 years Otani, Toshika Yokoyama, Hiroki Hanai, Ko Miura, Junnosuke Uchigata, Yasuko Babazono, Tetsuya Clin Pediatr Endocrinol Original Article The incidence of end-stage renal disease (ESRD) in Japanese patients with type 1 diabetes mellitus (T1DM) was investigated regarding the association between mean HbA1c values during follow-up and the duration of follow-up/illness. The study includes 988 patients diagnosed at ages younger than 30 yr. These patients were initially examined between 1962 and 1999, and HbA1 and/or HbA1c measurements were taken for at least 3 yr after 1980. The follow-up period was from the date of the first HbA1 or HbA1c measurement to the final measurement day, or HbA1c measurement day immediately before the development of ESRD. The condition progressed to ESRD in 63 patients (mean duration of illness: 23.6 yr). Cox regression analysis revealed that patients with HbA1c of ≥ 10% had a significantly increased higher risk than those with HbA1c under 8% (P < 0.0001). The HbA1c cut-off point was 10.0%. The HbA1c value was ≥ 10% at baseline and during follow-up in 128 patients. Assuming that HbA1c of ≥ 10% persisted since the time of diagnosis in these patients, the cumulative incidence of ESRD abruptly increased after 15 yr of illness. Thus, the incidence of ESRD increased after the persistence of HbA1c of ≥ 10% for 15 yr. The Japanese Society for Pediatric Endocrinology 2019-10-19 2019 /pmc/articles/PMC6801355/ /pubmed/31666764 http://dx.doi.org/10.1297/cpe.28.113 Text en 2019©The Japanese Society for Pediatric Endocrinology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License. (CC-BY-NC-ND 4.0: http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Otani, Toshika
Yokoyama, Hiroki
Hanai, Ko
Miura, Junnosuke
Uchigata, Yasuko
Babazono, Tetsuya
Rapid increase in the incidence of end-stage renal disease in patients with type 1 diabetes having HbA1c 10% or higher for 15 years
title Rapid increase in the incidence of end-stage renal disease in patients with type 1 diabetes having HbA1c 10% or higher for 15 years
title_full Rapid increase in the incidence of end-stage renal disease in patients with type 1 diabetes having HbA1c 10% or higher for 15 years
title_fullStr Rapid increase in the incidence of end-stage renal disease in patients with type 1 diabetes having HbA1c 10% or higher for 15 years
title_full_unstemmed Rapid increase in the incidence of end-stage renal disease in patients with type 1 diabetes having HbA1c 10% or higher for 15 years
title_short Rapid increase in the incidence of end-stage renal disease in patients with type 1 diabetes having HbA1c 10% or higher for 15 years
title_sort rapid increase in the incidence of end-stage renal disease in patients with type 1 diabetes having hba1c 10% or higher for 15 years
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801355/
https://www.ncbi.nlm.nih.gov/pubmed/31666764
http://dx.doi.org/10.1297/cpe.28.113
work_keys_str_mv AT otanitoshika rapidincreaseintheincidenceofendstagerenaldiseaseinpatientswithtype1diabeteshavinghba1c10orhigherfor15years
AT yokoyamahiroki rapidincreaseintheincidenceofendstagerenaldiseaseinpatientswithtype1diabeteshavinghba1c10orhigherfor15years
AT hanaiko rapidincreaseintheincidenceofendstagerenaldiseaseinpatientswithtype1diabeteshavinghba1c10orhigherfor15years
AT miurajunnosuke rapidincreaseintheincidenceofendstagerenaldiseaseinpatientswithtype1diabeteshavinghba1c10orhigherfor15years
AT uchigatayasuko rapidincreaseintheincidenceofendstagerenaldiseaseinpatientswithtype1diabeteshavinghba1c10orhigherfor15years
AT babazonotetsuya rapidincreaseintheincidenceofendstagerenaldiseaseinpatientswithtype1diabeteshavinghba1c10orhigherfor15years